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Hans Lederhuber*, Stephan Axer and Christof IhleAbstract
Background: Implantation of a gastric stimulator is a feasible surgical therapy for patients with therapy refractory
gastroparesis. In addition it seems to be a promising alternative for treating morbid obesity. We present for the first
time the surgical emergency of small bowel obstruction due to strangulation by gastric stimulator electrodes.
Case presentation: A 59-year-old Caucasian female had undergone implantation of a gastric stimulator to cope
with the symptoms of a partial gastroparesis. Eight years after the operation, the patient began to present repeatedly to
different hospitals because of abdominal pain and nausea. Symptoms and imaging indicated ileus, which could always
be treated conservatively. The underlying pathology could not ultimately be determined and the symptoms were
eventually considered gastroparesis-related. After two years the patient was finally referred in circulatory shock
due to peritonitis with underlying small bowel obstruction. Emergency laparotomy revealed small bowel strangulation
by the gastric stimulator electrodes.
Conclusion: Repeated presentation of a patient with an unfamiliar treatment modality must raise suspicion of
unusual complications. Specialist surgeons treating with innovative methods should provide proper information
that is accessible to everyone who might have to treat possible complications.
Keywords: Gastroparesis, Ileus, Implantable stimulation electrodesBackground
Implantable gastric stimulation is a method to stimulate
the stomach in order to overcome gastroparesis [1-6]
and to treat morbid obesity [7-10]. During a lapa-
roscopic intervention two electrodes are placed on the
anterior medial wall of the stomach. The distal end of
the electrodes is connected with the stimulation device,
which is implanted in a subcutaneous pocket in the
abdominal wall [4].
Patients with gastroparesis suffer from delayed empty-
ing of the stomach which can lead to varying problems
such as nausea, vomiting, abdominal pain and early
satiety with concomitant weight loss [11]. Gastroparesis
is not caused by mechanical obstruction but by abnor-
mal gastric myoelectric activity or abnormal gastric
motility [12]. There is a wide range of pathologies that* Correspondence: hans.lederhuber@liv.se
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unless otherwise stated.can lead to gastroparesis. Two well-known culprits are
diabetes mellitus [13] and vagotomy (e.g. due to index
gastric surgery) [14]. Nonetheless, some cases of gastro-
paresis have to be classified as idiopathic [15,16].
The traditional treatment of gastroparesis is in most
cases symptomatic. Some patients benefit from mere
diet modification, others need additional pharmacother-
apy [17,18]. However, long-term medication comes with
a range of side effects, which can deteriorate patients’
quality of life and therefore is not often tolerated. In
addition, there are a number of non-responders [19].
Surgical treatment of gastroparesis can be considered an
option when medical treatment has failed. Surgical treat-
ment includes gastrostomy or jejunostomy feeding tubes,
gastrectomy and gastric stimulation [20-24]. All surgical
treatment options of gastroparesis have in common that
evidence from randomized controlled trials for the
success of such intervention is lacking [25].
Nowadays, another indication for gastric stimulation is
morbid obesity. With obesity being a disease-entity withntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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cal therapies arose during the past years. However,
pharmacotherapy often comes with a range of unaccept-
able side effects [29,30]. Surgical intervention produces
long-term weight loss [31,32] however it’s invasive with
respective morbidity and mortality. Moreover, internal
herniation after laparoscopic gastric bypass procedures
has become a pending problem [33,34] and complica-
tions as well as limitations in this older-growing operated
population are not yet predictable [35]. Implantation of a
gastric stimulator represents a less invasive treatment
option for some patients. Although it is approved for
clinical use, it is not fully eluted how gastric stimulation
leads to weight loss.
Case presentation
A 59-year-old Caucasian female patient was referred to
our emergency department by ambulance from another
hospital where no operative service was available at
night. On arrival in the emergency department, the
patient presented in circulatory shock with pulse around
160 bpm and blood pressure 65/35 mmHg. Her labora-
tory results were remarkable for: pH acidic at 7.13,
pCO2 8.6 kPa, PO2 low at 5.3 kPa, lactate high at
9.2 mmol/L, BE −8.8 mmol/L. Her CRP was 48 mg/L
and WBC low normal at 3.5*109/L. On examination, she
showed all signs of general peritonitis. The patient was
prepared for emergency laparotomy immediately.
According to the patient’s journal records she had
undergone laparoscopic implantation of a gastric stimu-
lator in 2004 due to gastroparesis. The patient had a
medicated hypertension and a medicated hyperlipid-
aemia in her medical record but no further conditions.
She had earlier been operated with open surgery for
appendicitis, C-section and ovarian cysts. Between April
2012 and June 2014 the patient had shown up several
times to different hospitals in our county (Figure 1). She
had then presented with abdominal pain, bloating and
fever. Mechanical small bowel obstruction had been
suspected each time but either the CT scans had been
inconclusive or a sub-ileus condition had been resolved
during small bowel series. Discussion with the respective2004
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Figure 1 Timeline summarizing important clinical events.gastric surgeons had revealed that the patient had a
partial gastroparesis due to idiopathic neuropathy. The
patient’s symptoms had eventually been interpreted as
pseudo-obstruction and colonoscopy had been recom-
mended. This examination however had not shown any
pathology besides minor diverticulosis. The patient’s
recurring symptoms had got better after initiation of a
treatment with neostigmine and erythromycin before
meals. Follow-up at a gastrointestinal centre had been
planned. June 2014 the patient showed up to her nearest
hospital during early morning, once again with abdom-
inal pain and nausea. The abdominal tenderness was
focused around the umbilicus but physical examination
was otherwise without remark. Blood samples showed
CRP at 1 mg/L, WBC at 10.8*109/L. Body temperature
was 37.1°C, blood pressure 120/79 mmHg and pulse
51 bpm. The abdominal pain was assessed as functional
and the patient was sent home. The same evening how-
ever the patient was referred by ambulance to the same
hospital. She was tackycardic (around 140 bpm) and low
in blood pressure (about 75/50 mmHg). Body temperature
was 35.8°C. She had vomited several times before she had
ringed the ambulance. Clinically she presented this time
with peritonitis, no bowel sounds. After she’d been
stabilized initially a CT scan showed signs of small
bowel obstruction.
Our hospital was contacted when it became clear that
surgery was inevitable and that there were no resources
available at night at the other two nearer hospitals. This
was when the patient was referred and presented as
described above. After immediate admission to the oper-
ating room the abdomen was opened with a midline
laparotomy and bloody-serous fluid was found in the
abdominal cavity. Approximately two thirds of the small
bowel were necrotic. No adherences between the bowel
and the abdominal wall could be seen but interenteric
adherences were present without causing a stricture. We
identified that herniation of small bowel through the
loop of the stimulation-leads was causing a mechanical
strangulation ileus of the small bowel. To prevent recur-
ring strangulation, it was decided to cut the leads. The
strangulated bowel was not recovering and had to be06/2014
esenting with abdominal pain 
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end-to-end enteroentero-anastomosis. The patient was
left with 120 cm small bowel (Figure 2). The leads were
shortened to the level of the abdominal wall and the
stimulation device was left in place. Perioperatively a
treatment with cefotaxime and metronidazole was started
according to national standards. The patient was extu-
bated the first postoperative day and was able to be
discharged from our hospital on the eighth postope-
rative day.
Two months later the patient was seen in our day-
clinic for follow up and for explanting the stimulation
device under local anaesthesia. She was feeling well but
experiencing some symptoms of her gastroparesis anew.
Conclusions
Gastroparesis and morbid obesity are two quite different
conditions. However, they have both close relations to
the gastrointestinal tract. Both conditions can be treated
by diet modification or pharmacotherapy. These condi-
tions also have in common that the first and the latter
therapeutical approaches use to fail in certain patients
for a variety of reasons. This is why surgical strategies
exist for gastroparesis as well as morbid obesity.
The backdraft of surgical therapy is that it always
comes with morbidity and mortality. The attempt to
overcome these limitations can be seen as the incitement
to develop new and better surgical techniques and has
led to the surgical state of art we see today.
Compared to gastrectomy or Roux-en-Y gastric bypass,
the implantation of two electrodes during minimal inva-
sive surgery is by far less invasive. The possibility to
merely switch off the stimulation device if needed is
even more alluring as gastrectomy is not reversible and
reversion of a gastric bypass is challenging. However, as
seen in the case presented, not even implantation of aFigure 2 Stimulation leads strangulating parts of the small bowel.
The white arrow marks the leads.gastric stimulator is totally risk-free. The issue of sti-
mulator placement, lead length and lead placement in
particular might be worth to raise if adverse events
should occur more frequently.
Presenting this extremely rare case of small bowel
strangulation, we want to highlight some major concerns
that we think can be transferred to similar scenarios:
Using novel treatment approaches is desirable when it
comes with a benefit for the patient but complications
after such treatment must be managed professionally.
One gets into situations of vague ethical boundaries when
this management fails due to lack of knowledge of the
new approach. Similar problems were seen some years
ago when the first patients presented to emergency de-
partments around the country with internal herniation
after gastric bypass surgery. It was widely unknown that
such a complication even existed, especially as many
patients did not present to a bariatric center but to
some hospital nearby with a general surgeon in charge.
A general surgeon should not be expected to be capable
of solving an internal herniation laparoscopically. But
every general surgeon nowadays has to know the pos-
sible complications and the workup of a patient who
has undergone bariatric surgery and is now presenting
with abdominal pain and nausea.
In the case presented the knowledge transfer from the
center where the gastric stimulator had been implanted
to the patient’s nearest county hospitals had probably
not been optimal. Potential pitfalls and especially hernia-
tion risk had obviously not been pinpointed clearly
enough. And here we address the gist of this case: what
might seem obvious for a sub-specialist surgeon who is
dealing with a condition on a daily basis might not be
obvious at all for a general surgeon who is not even
aware of the problem. Thus it would be desirable if sub-
specialists who apply techniques that are not common
surgical knowledge would provide proper documenta-
tion, patient information and above all, knowledge trans-
fer to their colleague surgeons. On the other hand, this
case also demonstrates the responsibility of the local
general surgeon. Patients with an unfamiliar treatment
modality who repeatedly present to the emergency de-
partment must raise suspicion. If additional workup is
inconclusive, close contact to the sub-specialists seems
advisable. Finally it might be recommended to consider
falling back upon basic surgical procedures. In the case
presented, diagnostic laparoscopy would have been a fast
forward procedure with limited risks and high potential
to spot the problem.
In conclusion we want to summarize that the descrip-
tion of small-bowel strangulation through leads of a
gastric stimulator might be a zebra, but cases like this
should raise awareness for the problems that come with
the introduction of new surgical techniques.
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